Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.
Bio-Techne
WHERE SCIENCE INTERSECTS INNOVATIONTM
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/DATA_GCSF_MCS00_ELISA_959.jpg "G-CSF [HRP]")
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/G-CSF_MCS00_ELISA_254.jpg)
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/DATA_GCSF_DCS50_ELISA_637.jpg "G-CSF [HRP]")
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/DATA_GCSF_DCS50_ELISA_638.jpg)
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/G-CSF_DCS50_ELISA_70.jpg)
![G-CSF [Biotin]](http://images.novusbio.com/fullsize2/DATA_GCSF_DY414_ELISA_2011.jpg "G-CSF [Biotin]")
![G-CSF [Biotin]](http://images.novusbio.com/fullsize2/DATA_GCSF_DY214_ELISA_1772.jpg "G-CSF [Biotin]")
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/G-CSF_HSCS0_ELISA_401.jpg "G-CSF [HRP]")
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/DATA_GCSF_HSCS0_ELISA_899.jpg)
![G-CSF [HRP]](http://images.novusbio.com/fullsize2/DATA_GCSF_HSCS0_ELISA_900.jpg)
![Western Blot: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(7E4F7)-Western-Blot-NBP2-52447-img0004.jpg "Western Blot: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)")
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (7E4F7) [NBP2-52447] - Immunofluorescence analysis of A549 cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(7E4F7)-Immunofluorescence-NBP2-52447-img0001.jpg)
![Immunohistochemistry: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis of paraffin-embedded esophageal cancer tissues using CSF3 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(7E4F7)-Immunohistochemistry-NBP2-52447-img0003.jpg)
![Western Blot: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis using CSF3 mAb against HEK293 (1) and CSF3 (AA: 1-207)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize2/G-CSF Antibody (7E4F7)-Western Blot-NBP2-52447-img0005.jpg)
![Immunohistochemistry: G-CSF Antibody (7E4F7) [NBP2-52447] - Analysis of Hela cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(7E4F7)-Immunohistochemistry-NBP2-52447-img0002.jpg)
![ELISA: G-CSF Antibody (7E4F7) [NBP2-52447] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(7E4F7)-ELISA-NBP2-52447-img0006.jpg)
![Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(8G5F7)-Western-Blot-NBP2-52448-img0004.jpg "Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)")
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of Hela cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(8G5F7)-Immunofluorescence-NBP2-52448-img0003.jpg)
![Flow Cytometry: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of A549 cells using CSF3 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(8G5F7)-Flow-Cytometry-NBP2-52448-img0001.jpg)
![Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against HEK293 (1) and CSF3 (AA: 1-207)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize2/G-CSF Antibody (8G5F7)-Western Blot-NBP2-52448-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of A549 cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(8G5F7)-Immunofluorescence-NBP2-52448-img0002.jpg)
![ELISA: G-CSF Antibody (8G5F7) [NBP2-52448] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize2/G-CSF-Antibody-(8G5F7)-ELISA-NBP2-52448-img0006.jpg)